Stock 3320 CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company China Resources Pharmaceutical Group Limited

Equities

3320

HK0000311099

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:04 19/06/2024 pm IST 		5-day change 1st Jan Change
6.02 HKD +2.91% Intraday chart for China Resources Pharmaceutical Group Limited +4.88% +17.35%
11/06 China Resources Pharmaceutical to Cut Stake in Subsidiary MT
07/06 China Resources Pharmaceutical Group Limited Announces Directorate Changes CI

Business Summary

CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The Company mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong.

Number of employees: 72,986

Sales per Business

HKD in Million2022Weight2023Weight Delta
Distribution
80.0 %
205,062 80.7 % 195,858 80.0 % -4.49%
Manufacturing
16.0 %
40,167 15.8 % 39,190 16.0 % -2.43%
Retail
3.9 %
8,837 3.5 % 9,579 3.9 % +8.40%
Others
0.0 %
41 0.0 % 76 0.0 % +87.21%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
99.4 %
253,501 99.8 % 243,114 99.4 % -4.10%
Others
0.6 %
-- 1,590 0.6 % -

Managers

Managers TitleAgeSince
Xiao Song Bai CEO
 Chief Executive Officer 52 14/22/14
Rong Hui Deng DFI
 Director of Finance/CFO 46 13/23/13
Yue Wei Han CHM
 Chairman 56 22/19/22

Members of the board

Members of the board TitleAgeSince
Rui Fang Jiao BRD
 Director/Board Member 47 14/22/14
Ting Mei Fu BRD
 Director/Board Member 57 01/16/01
Ke Jian Zhang BRD
 Director/Board Member 68 20/16/20
Kin Fun Kwok BRD
 Director/Board Member 73 20/16/20
Wei Guo BRD
 Director/Board Member 47 29/19/29
Ran Tao BRD
 Director/Board Member 59 07/21/07
Mo Han Shing BRD
 Director/Board Member 68 07/17/07
Yue Wei Han CHM
 Chairman 56 22/19/22
Rong Hui Deng DFI
 Director of Finance/CFO 46 13/23/13
Xiao Song Bai CEO
 Chief Executive Officer 52 14/22/14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 6,282,510,461 1,755,919,500 ( 27.95 %) 0 27.95 %

Shareholders

NameEquities%Valuation
China State-Owned Assets Supervision & Admn Commission
53.05 %
3,333,185,612 53.05 % 2 467 M $
City of Beijing
17.43 %
1,094,800,000 17.43 % 810 M $
Beijing Equity Investment Development Fund Cayman Ii LP
2.586 %
162,438,849 2.586 % 120 M $
Fullgoal Fund Management Co., Ltd.
0.2466 %
15,490,000 0.2466 % 11 M $
Bosera Asset Management Co., Ltd.
0.2339 %
14,694,000 0.2339 % 11 M $
Robeco Hong Kong Ltd.
0.1512 %
9,499,500 0.1512 % 7 M $
China Asset Management Co., Ltd.
0.1369 %
8,599,500 0.1369 % 6 M $
Zhong Ou Asset Management Co., Ltd
0.1047 %
6,580,000 0.1047 % 5 M $
Research Affiliates LLC
0.0918 %
5,768,500 0.0918 % 4 M $
State Street Global Advisors Ltd.
0.0637 %
4,004,869 0.0637 % 3 M $

Holdings

NameEquities%Valuation
CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.
63.63%
 622,569,632 63.63% 5,228,756,891 $
DONG-E-E-JIAO CO.,LTD.
32.01%
 209,286,847 32.01% 1,956,214,623 $
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.
61.09%
 625,795,624 61.09% 1,827,974,050 $
JIANG ZHONG PHARMACEUTICAL CO.,LTD
43.46%
 271,071,486 43.46% 975,542,907 $
CHINA RESOURCES BOYA BIO-PHARMACEUTICAL GROUP CO.,LTD
100.00%
 78,308,575 100.00% 355,869,404 $
TYCOON GROUP HOLDINGS LIMITED
18.99%
 151,895,000 18.99% 76,691,786 $

Company contact information

China Resources Pharmaceutical Group Ltd.

China Resources Building 26 Harbour Road

, Hong Kong

+852 2593 8991

http://www.crpharm.com
address China Resources Pharmaceutical Group Limited(3320)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for China Resources Pharmaceutical Group Limited

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
6.02 HKD
Average target price
7.382 HKD
Spread / Average Target
+22.62%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED Stock China Resources Pharmaceutical Group Limited
+17.35% 470.71Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+52.93% 80TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.98% 63TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.08% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.40% 32TCr
ABBVIE INC. Stock AbbVie Inc.
+10.58% 30TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.42% 24TCr
ROCHE HOLDING AG Stock Roche Holding AG
+2.17% 23TCr
NOVARTIS AG Stock Novartis AG
+10.66% 21TCr
AMGEN INC. Stock Amgen Inc.
+6.24% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 3320 Stock
  4. Company China Resources Pharmaceutical Group Limited